Skip to main content
SpringerLink
Log in

Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Background: Nitric oxide (NO), hydroxyl radical (OH.), superoxide anion (O2 −) and hydrogen peroxide (H2O2) are free-radicals released in oxidative stress. Superoxide dismutase (SOD), glutathione peroxidase (GSHPx) and catalase (CAT) are antioxidant enzymes, mediating defense against oxidative stress. Excess NO and/or defective antioxidants cause lipid peroxidation, cellular dysfunction and death. Age-related maculopathy (ARM) or degeneration (ARMD) is the leading cause of irreversible blindness in developed countries. The etiology is unclear and the molecular factors contributing this disease remain to be specified. Aims: This multicenter, double-blind, cross-sectional study aimed to investigate plasma NO and lipid peroxidation levels with relation to antioxidant enzyme activities in erythrocyte and plasma of patients with ARMD compared with healthy control subjects. Methods: NO, lipid peroxidation (measured as plasma malondialdehyde [MDA] levels) and the catalytic activity of SOD, GSHPx and CAT were measured in a group of 41 patients with maculopathy (19 men, 22 women; 67.12 ± 3.70 years) and compared with 25 age- and sex-matched healthy control subjects without maculopathy (12 men, 13 women; 68.04 ± 3.02 years). NO and MDA levels were measured in plasma, CAT in red blood cells (RBCs), and SOD and GSHPx in both plasma and RBCs. Color fundus photographs were used to assess the presence of maculopathy, and the patients were divided into two groups using clinical examination and grading of photographs; early-ARM (n = 22) and late-ARMD (n = 19). Results: All patients with maculopathy had significantly (p<0.001) higher plasma NO levels over control subjects (mean ± SD, 48.58 ± 8.81 vs. 28.22 ± 3.39 μmol/l). Plasma MDA levels in patients and control subjects were 4.99 ± 1.00 and 2.16 ± 0.24 μmol/l, respectively, and the difference was significant (p<0.001). On the other hand, SOD and GSHPx activities were significantly lower in both RBCs and plasma of patients with maculopathy than in control subjects (RBCs-SOD, 3509.30 ± 478.22 vs. 5033.30 ± 363.98 U/g Hb, p<0.001; plasma-SOD, 560.95 ± 52.52 vs. 704.76 ± 24.59 U/g protein, p<.001; RBCs-GSHPx, 663.43 ± 41.74 vs. 748.80 ± 25.50 U/g Hb, p<0.001; plasma-GSHPx, 98.26 ± 15.67 vs. 131.80 ± 8.73 U/g protein, p<0.001). RBCs-CAT levels were not different between groups (131.68 ± 12.89 vs. 133.00 ± 13.29 k/g Hb, p=0.811). Late-ARMD patients had significantly lower antioxidant enzyme levels and higher MDA levels when compared with early-ARM patients (for each, p<0.001). In addition, plasma NO and MDA levels were negatively correlated with SOD and GSHPx activities. Conclusions: This study demonstrated for the first time that NO, the most abundant free-radical in the body, might be implicated in the pathophysiology of ARMD in association with decreased antioxidant enzymes and increased lipid peroxidation status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy. Ophthalmology 1997; 104: 7–21.

    Google Scholar 

  2. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration: The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367–74.

    Google Scholar 

  3. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992; 110: 1701–8.

    Google Scholar 

  4. Christen WG Jr. Antioxidants and eye disease. Am J Med 1994; 97: 14–7.

    Google Scholar 

  5. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995; 142: 404–9.

    Google Scholar 

  6. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805–7.

    Google Scholar 

  7. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998; 116: 583–7.

    Google Scholar 

  8. Gerster H. Review: antioxidant protection of the ageing macula. Age Ageing 1991; 20: 60–9.

    Google Scholar 

  9. Pastor MC, Sierra C, Dolade M, et al. Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients. Clin Chem 1998; 44: 924–9.

    Google Scholar 

  10. Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res 2000; 40: 33–9.

    Google Scholar 

  11. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547–81.

    Google Scholar 

  12. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527–605.

    Google Scholar 

  13. Sozmen EY, Kerry Z, Uysal F, et al. Antioxidant enzyme activities and total nitrite/nitrate levels in the collar model. Effect of nicardipine. Clin Chem Lab Med 2000; 38: 21–5.

    Google Scholar 

  14. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial cell injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620–4.

    Google Scholar 

  15. Hirvela H, Luukinen H, Laara E, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996; 103: 871–7.

    Google Scholar 

  16. Klein R, Davis M, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128–34.

    Google Scholar 

  17. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 1996; 268: 142–51.

    Google Scholar 

  18. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. Increased serum nitric oxide levels in patients with Behçet's disease: is it a new activity marker? J Am Acad Dermatol 2002; 46: 50–4.

    Google Scholar 

  19. Wasowics W, Neve J, Peretz A. Optimized steps in flourometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2522–6.

    Google Scholar 

  20. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497–500.

    Google Scholar 

  21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–69.

    Google Scholar 

  22. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121–6.

    Google Scholar 

  23. Lowry OH, Rosenbrough NJ, Farr AL. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.

    Google Scholar 

  24. Tso MO. Retinal photic injury in normal and scorbutic monkeys. Trans Am Ophthalmol Soc 1987; 85: 498–556.

    Google Scholar 

  25. Alexander LJ. Age-related macular degeneration: the current understanding of the status of clinicopathology, diagnosis and management. J Am Optom Assoc 1993; 64: 822–37.

    Google Scholar 

  26. Crastes de Paulet A. Free radicals and aging. Ann Biol Clin 1990; 48: 323–30.

    Google Scholar 

  27. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000; 19: 205–21.

    Google Scholar 

  28. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991; 91: 14–22.

    Google Scholar 

  29. Guemouri L, Artur Y, Herbeth B, Jeandel C, Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 37: 1932–7.

    Google Scholar 

  30. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res 1996; 36: 2979–94.

    Google Scholar 

  31. Muijsers RB, Folkerts G, Henricks PA, Sadeghi-Hashjin G, Nijkamp FP. Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci 1997; 60: 1833–45.

    Google Scholar 

  32. Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15: 53–9.

    Google Scholar 

  33. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768–70.

    Google Scholar 

  34. Goureau O, Jeanny JC, Becquet F, Hartmann MP, Courtois Y. Protection against light-induced degeneration by an inhibitor of NO synthase. Neuroreport 1993; 5: 233–6.

    Google Scholar 

  35. De La Paz M, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 1992; 33: 3497–9.

    Google Scholar 

  36. Wassell J, Davies S, Bardsley W, Boulton M. The photoreactivity of the retinal age pigment lipofuscin. J Biol Chem 1999; 274: 23828–32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Erciyes University;Inönü University, Medical Faculty, Turgut Ozal Medical Center, Turkey

    Cem Evereklioglu

  2. Research and Application Hospital, Gaziantep University Medical Faculty, Turkey

    Cem Evereklioglu

  3. Turgut Ozal Medical Center, Inönü University, Medical Faculty, Turkey

    Hamdi Er, Selim Doganay, Mustafa Cekmen, Yusuf Turkoz, Baris Otlu & Elif Ozerol

Authors
  1. Cem Evereklioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamdi Er
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Selim Doganay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mustafa Cekmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yusuf Turkoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Baris Otlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elif Ozerol
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evereklioglu, C., Er, H., Doganay, S. et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 106, 129–136 (2003). https://doi.org/10.1023/A:1022512402811

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022512402811

Search

Navigation